Navigation Links
BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data
Date:11/15/2007

BRUSSELS, Belgium and BRISBANE, Calif., Nov. 15 /PRNewswire/ -- BiPar Sciences, Inc., a privately held biopharmaceutical company developing novel cancer therapies, today announced it has initiated a Phase 2 study of its lead PARP inhibitor, BSI-201, in patients with triple-negative breast cancer that do not express the estrogen, progesterone or HER2 receptors.

The company designed the Phase 2 trial in this indication-which represents a major unmet medical need-based on molecular biomarker data presented today showing that breast tumors that are estrogen-negative and progesterone- negative were more likely to overexpress PARP, as were HER2-negative tumors. The data were presented at European Organization for Research and Treatment of Cancer-National Cancer Institute-American Society for Clinical Oncology Annual Meeting on "Molecular Markers in Cancer" in Brussels.

"Our research shows clearly that not only is PARP overexpressed in breast tumors generally, it is even more likely to be overexpressed in triple- negative tumors. That suggests that PARP inhibition may be a particularly effective way to target those hard-to-treat cancers," said BiPar Executive Vice President Barry Sherman, M.D. "Our Phase 2 trial of BSI-201 will build on those insights and, if successful, will serve as powerful proof of our strategy to use molecular biomarker data to focus our clinical studies of BiPar's PARP inhibitors on tumors that markedly upregulate PARP."

Patients with triple-negative breast cancer, who make up 10 to 15 percent of all patients, have few effective therapeutic options. Neither targeted therapies such as Herceptin and Tykerb nor anti-estrogens such as tamoxifen provide a benefit, and triple-negative tumors are associated with a high rate of relapse. Such cancers are particularly prevalent in premenopausal African- American women.

"We are very excited about being able to offer patients with triple- negative metastatic breast cancer treatment
'/>"/>

SOURCE BiPar Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
2. BiPar Announces Preclinical Data Demonstrating Anti-Tumor Activity With BSI-401, Its Second-Generation PARP Inhibitor
3. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
4. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
5. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
6. Enrollment Begins on Human PK Study for Medidur(TM) FA
7. Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
8. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
9. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
10. Metabolex Begins Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia
11. DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... , Nov. 21, 2014  Particle Sciences, Inc ... has developed and manufactured a new innovative vaginal ... Research and Development arm of Exeltis Pharmaceuticals.  According ... Project Management at Particle Sciences, "This vaginal ring ... our material sciences and modeling expertise.  We are ...
(Date:11/21/2014)... Md. , Nov. 21, 2014  The University ... will host the ceremonial groundbreaking of the new A. ... Park. The new building will cultivate transformative new engineering ... Taking place at 10:00 a.m. on November ... the Paint Branch Parking Lot, adjacent to the Jeong ...
(Date:11/21/2014)... Fla. , Nov. 21, 2014   Rock ... announced that the Company is scheduled to present at ... San Francisco, CA on January 12-14, 2015. ... Chairman and CEO of Rock Creek Pharmaceuticals, will present ... molecule cholinergic agonist which exhibits anti-inflammatory pharmacological characteristics. Dr. ...
Breaking Medicine Technology:Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4
... DIEGO, June 10, 2011 Gen-Probe Incorporated (NASDAQ: ... the William Blair & Company 31st Annual Growth Stock Conference ... Central Time (5 p.m. Eastern Time).  The presentation is scheduled ... link on the investors section of Gen-Probe,s website at ...
... HANOVER, N.J., June 10, 2011 Unity Management ... is a Health Resource Company specializing in Physician ... and Technologies, along with Pharmacy Instrumentation, Calibration, Data ... is pleased to announce today that (MCC) Metropolitan ...
Cached Medicine Technology:Gen-Probe to Webcast Presentation at the William Blair & Company 31st Annual Growth Stock Conference 2Unity Management Group, MCC Announce Increased Contracts and Major Installations at US and South American Pharmaceutical Companies 2Unity Management Group, MCC Announce Increased Contracts and Major Installations at US and South American Pharmaceutical Companies 3
(Date:11/24/2014)... Pittsburgh, PA (PRWEB) November 24, 2014 ... as he was trying to cross the street in ... "The driver never saw him. I came up with ... easily visible at night." , He developed the Safety ... night or in low-lighting conditions. The device ensures that ...
(Date:11/23/2014)... November 24, 2014 For the coming ... retailer, has launched a great promotion for many products, ... Customers can get the best choice with amazing discounts, ... at Tidebuy.com. , It is easy to buy ... Besides that, this selection is also famous for delicate ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 Pro Ace Care, ... that it will now be providing an 8 year warranty ... hot water tank installations went up due to the impending ... assure its customers of the premium service that the company ... 8 year warranty on John Wood and Bradford hot water ...
(Date:11/23/2014)... News) -- The holidays can be a challenge for ... trigger major meltdowns, an expert says. "Holidays with ... but when you have children with special needs, some ... professor at University of the Sciences in Philadelphia, said ... let your hosts or visitors know what special requirements ...
(Date:11/23/2014)... November 23, 2014 To show thanks to ... new collection of white evening dresses for weddings. ... workers 24/7. , iFitDress.com is a distinguished dress manufacturer, and ... supported by worldwide customers for a very long time. The ... where a customer will be able to buy not only ...
Breaking Medicine News(10 mins):Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2
... It has now been found that consumption of hot or ... can lead to drastic fluctuations in temperature measurement. // Consuming ... the restoration of body temperature to baseline levels by 15 ... of Virginia Health System have conducted this interesting research. So ...
... financial crisis would put an end to the new scheme, which ... ,This scheme comes under the National Health Center (NHS). ... transferring the powers to the regional health bosses. ... by few of the hospitals that come under the NHS. ...
... through watching the consequences of the habit in real life, ... Center in Durham. This is particularly so while taking care ... A telephone counseling program has also been designed by Bastian ... weeks which is inclusive of instructions with regard to dealing ...
... peramivir, claimed to be a highly potent formulation for combating ... been credited with a fast-track review by the Food and ... by the pharmaceutical company BioCryst can be injected intravenously. Promising ... bird flu strains. If successful and approved we could soon ...
... Canadians are becoming increasingly obese, according to a new study. The ... risen to 1.3% in 2003, from the 1990 figure of 0.3%, ... (BMI) is made use of by Health Canada for measuring obesity, ... overweight, and if it crosses 30, it is a case of ...
... is facing an increased threat of bird flu as new cases ... WHO Western Pacific has said though// Asian countries are planning and ... lot should have been done and should be done to prevent ... due to bird flu infection in East Asia since the re-emergence ...
Cached Medicine News:Health News:Mummy Is Always Right: Nurses Research Prove It Over Again 2Health News:New UK Policy Threatens The Flexible Working Scheme 2
Taber's Cyclopedic Medical Dictionary is published by F.A. Davis. Contains approximately 56,000 terms....
The American Heritage® Stedman's Medical Dictionary is a work for consumers and patients concerned with medicine and health today....
With Skyscape's smARTlink technology, Tabers can cross-index with other clinical and drug prescription products from Skyscape to provide an integrated source of clinical information....
... makes the patient appointment, the charge capture ... MedPlexus System accessible through a hand-held ... access to data that was previously available ... schedules, create super bills and more. The ...
Medicine Products: